Services
May 20, 2013
Four decades delivering contract pharma solutions for our partners
Alkermes Contract Pharma Services provides solid dosage form product development, scale-up and manufacturing services along with sterile fill-finish capabilities to the global pharma…
Read More »
May 20, 2013
Alkermes Contract Pharma Services
As part of Alkermes plc, Alkermes Contract Pharma Services provides solid oral dosage product development, scale-up and manufacturing services as well as sterile fill finish capabilities to the global pharmaceutical…
Read More »
May 20, 2013
Engine of Innovation
Along with our deep scientific expertise and unique patient-inspired focus, our proprietary technological and manufacturing capabilities form the foundation for Alkermes’ commitment to science with a purpose. Not coin…
Read More »
March 15, 2013
In addition to Wockhardt's development and finished dosage form capabilities, we boast a state-of-the-art cGMP compliant API manufacturing facility approved by the USFDA and UKMHRA.
Key Manufacturing Capabilities & Attributes:
State-of…
Read More »
March 15, 2013
With Wockhardt's state of the art sterile injectable facility based in Wrexham in the UK, we are able to handle and process controlled drug substances with its long established UK Home Office license (Schedule 1 & 2). At the request of the cl…
Read More »
March 15, 2013
The recent acquisition of Pinewood Healthcare in Southern Ireland has expanded Wockhardt's production capabilities for:
Non Beta-Lactam Sachets & Powders (Non-Penicillin Powders)
Oral Liquids and Suspensions
Creams and Ointment…
Read More »
March 15, 2013
Pinewood Healthcare in Southern Ireland has expanded Wockhardt's production capabilities for non beta-lactam sachets & non-penecilin powders, oral liquids / suspensions, creams and ointments.
Established in 1976, Pinewood employs 350-400 peo…
Read More »
March 15, 2013
With over twenty-five years of experience, Wockhardt is equipped with all the expertise necessary to supply quality solid dose formats to our clients. Our Solid Dose facilities provide manufacturing and packing for both plain tablets and film or su…
Read More »
March 15, 2013
Our Indian plant offers a purpose built, fully automated lyophilisation facility consisting of two 30m² freeze-driers, a total of 60m² freeze-drying capacity. Utilising the latest technology, this facility will offer scale-up and commercial…
Read More »
March 15, 2013
Utilising the extensive production facilities at Wockhardt, we have been manufacturing sterile injectable products for our clients for over twenty-five years.
Wockhardt is already partner of choice for the manufacturing of a major new patented US dr…
Read More »
March 15, 2013
Wockhardt understands that good technology transfer practice is essential to complement good manufacturing practice. Our process is second to none in delivering exceptional quality. The goal of the technology transfer process is to establish consiste…
Read More »
March 15, 2013
Pre Formulation & Formulation Development:
With scale-up, technology transfer and commercialisation at the forefront of our thoughts, we are able to optimise your molecules development in line with your marketing and time-line requirements. Wockh…
Read More »
March 15, 2013
Wockhardt's Business & Project Managers are the window to our company. They work closely with development and operational groups to ensure your timelines are met. The Business & Project Managers are responsible for ensuring communication…
Read More »
September 7, 2012
Our special packaging options can make a difference.
One 2 One special packaging options offer unique systems to protect patients and healthcare providers, or provide custom solutions that can ease drug administration process.
Onco-Tain™ Vi…
Read More »
September 7, 2012
The advantages for emulsion-based formulations are clear.
With expertise in pharmaceutical disperse systems, One 2 One is a clear leader in the development and manufacture of emulsion-based formulations. The ability to dissolve lipophilic component…
Read More »
